Therapeutic Targeting of Protein Tyrosine Phosphatases from <i>Mycobacterium tuberculosis</i>
Tuberculosis (TB) is an airborne infectious disease caused by <i>Mycobacterium tuberculosis</i> (Mtb). According to the World Health Organization, an estimated 10 million people developed TB in 2018. The occurrence of drug-resistant TB demands therapeutic agents with novel mechanisms of...
Main Authors: | Kasi Viswanatharaju Ruddraraju, Devesh Aggarwal, Zhong-Yin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/1/14 |
Similar Items
-
Flavonoid Mixture Inhibits <i>Mycobacterium tuberculosis</i> Survival and Infectivity
by: Ruoqiong Cao, et al.
Published: (2019-02-01) -
Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
by: Elisa Pardella, et al.
Published: (2020-09-01) -
Amphotericin B as a mycolic acid specific targeting agent in tuberculosis
by: Benadie, Yolandy
Published: (2013) -
Inactivation of Protein Tyrosine Phosphatases by Peracids Correlates with the Hydrocarbon Chain Length
by: Alicja Kuban-Jankowska, et al.
Published: (2015-06-01) -
Effect of common and experimental anti-tuberculosis treatments on Mycobacterium tuberculosis growing as biofilms
by: James P. Dalton, et al.
Published: (2016-11-01)